Evidence map›Paper›PMID 24721741›Full record

ReviewJournal of lipid research2014

The collective therapeutic potential of cerebral ketone metabolism in traumatic brain injury.

Mayumi L Prins, Joyce H Matsumoto

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 108 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. New insights into metabolism dysregulation after TBI.Journal of neuroinflammation · 2024
    Review
  9. Review
  10. Review
  11. Tracing the path of disruption:CNS neuroscience & therapeutics · 2024
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mayumi L PrinsDepartment of Neurosurgery, Brain Injury Research Center University of California, Los Angeles, Los Angeles, CA.
Joyce H MatsumotoDepartment of Pediatrics, Division of Pediatric Neurology, University of California, Los Angeles, Los Angeles, CA.
University of California, Los Angeles · US

Funding

Cerebral Substrate Support After Traumatic Brain InjuryR01NS104311 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRINS, MAYUMI LYNN · 2018 to 2022
$1.7M
NINDS NIH HHS R01 NS104311
6 · The paper itself

Abstract

The postinjury period of glucose metabolic depression is accompanied by adenosine triphosphate decreases, increased flux of glucose through the pentose phosphate pathway, free radical production, activation of poly-ADP ribose polymerase via DNA damage, and inhibition of glyceraldehyde dehydrogenase (a key glycolytic enzyme) via depletion of the cytosolic NAD pool. Under these post-brain injury conditions of impaired glycolytic metabolism, glucose becomes a less favorable energy substrate. Ketone bodies are the only known natural alternative substrate to glucose for cerebral energy metabolism. While it has been demonstrated that other fuels (pyruvate, lactate, and acetyl-L-carnitine) can be metabolized by the brain, ketones are the only endogenous fuel that can contribute significantly to cerebral metabolism. Preclinical studies employing both pre- and postinjury implementation of the ketogenic diet have demonstrated improved structural and functional outcome in traumatic brain injury (TBI) models, mild TBI/concussion models, and spinal cord injury. Further clinical studies are required to determine the optimal method to induce cerebral ketone metabolism in the postinjury brain, and to validate the neuroprotective benefits of ketogenic therapy in humans.

Indexed as

Diet, KetogenicEnergy MetabolismEvidence-Based MedicineAnimalsBrain ConcussionBrain InjuriesCerebral CortexDietary SupplementsDown-RegulationGlycolysisHumansInfusions, IntravenousInfusions, SpinalKetone BodiesKetonesNeuronsKetone BodiesKetonesalternative substratesneuroprotectionβ-hydroxybutyrate

Identifiers

PMID24721741
PMCPMC4242438
OpenAlexW1990210604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.